Safety assessments
treatment-emergent adverse
ADVERSE EVENTS
Evaluations of safety were performed using information gathered from clinical laboratory tests, abdominal ultrasonography, vital signs, electrocardiograms, and physical examinations, as well as from reports of adverse events (AEs). AEs that appeared for the first time or were worse during the double-blind phase were known as treatment-emergent adverse events (TEAE).